Milestone Pharmaceuticals
Latest round
- Series C
Last raised
- Aug 2017
Total raised
- $88M
Investors
- 10
About Milestone Pharmaceuticals
Based in Quebec, Canada, and founded in 2005 by founder Philippe Douville, Milestone Pharmaceuticals, Inc. operates as a biopharmaceutical company providing the treatment of paroxysmal supraventricular tachycardia. As of 2024, the firm is listed on NASDAQ with ticker symbol MIST. In February 2024, Milestone Pharmaceuticals, Inc.50 per share in the NASDAQ. The company has granted the underwriters a 30-day option to purchase up to 3,000,000 common shares at the public offering price. Milestone Pharmaceuticals, Inc. developed an investigational product known as etripamil, which is a novel calcium channel blocker delivered as a nasal spray. The company’s product is designed for the acute at-home treatment of PSVT and AFib-RVR, allowing patients to manage their heart rhythm disturbances wherever they may be.S. Food and Drug Administration (FDA) for etripamil, highlighting its potential to transform the standard of care for these conditions.
Who invested in Milestone Pharmaceuticals
10 investors across 4 rounds
See all investors in Milestone Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Milestone Pharmaceuticals
Who invested in Milestone Pharmaceuticals?
Milestone Pharmaceuticals has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Milestone Pharmaceuticals raised?
Milestone Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Milestone Pharmaceuticals last raise money?
Milestone Pharmaceuticals's most recent round on record is a Series C, in Aug 2017.
What does Milestone Pharmaceuticals do?
Based in Quebec, Canada, and founded in 2005 by founder Philippe Douville, Milestone Pharmaceuticals, Inc.
Where is Milestone Pharmaceuticals headquartered?
Milestone Pharmaceuticals is headquartered in Canada.
Which VCs invest in companies like Milestone Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Milestone Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Milestone Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.